These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29187718)

  • 21. Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis.
    Scher RK; Nakamura N; Tavakkol A
    Mycoses; 2014 Jul; 57(7):389-93. PubMed ID: 24621346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
    Gupta AK; Paquet M
    J Cutan Med Surg; 2014; 18(3):151-5. PubMed ID: 24800702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Nail Penetration and Antifungal Activity of Tavaborole, a Boron-Based Pharmaceutical.
    Coronado D; Merchant T; Chanda S; Zane LT
    J Drugs Dermatol; 2015 Jun; 14(6):609-14. PubMed ID: 26091387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Elewski BE; Pollak RA; Pillai R; Olin JT
    J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro Antifungal Activity of Luliconazole against Trichophyton spp].
    Maeda J; Nanjoh Y; Koga H; Toga T; Makimura K; Tsuboi R
    Med Mycol J; 2016; 57(1):J1-6. PubMed ID: 26936346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Topical Antifungal Luliconazole on Hyphal Morphology of Trichophyton mentagrophytes Grown on in vitro Onychomycosis Model.
    Nishiyama Y; Maeda M; Yamada T
    Mycopathologia; 2022 Dec; 187(5-6):491-496. PubMed ID: 36057744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case of Nail Yellow Discoloration due to Topical Treatment of Onychomycosis with Luliconazole 5% Nail Solution.
    Sato T; Fukada N; Kinjo A; Akimoto R; Kobayashi H; Fukuzumi S
    Med Mycol J; 2023; 64(2):45-47. PubMed ID: 37258134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tinea and Onychomycosis.
    Rosen T
    Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S110-3. PubMed ID: 27537822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
    Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
    Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success.
    Pollak RA; Siu WJJ; Tatsumi Y; Pillai R
    J Fungi (Basel); 2015 Jul; 1(2):107-114. PubMed ID: 29376902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.
    Vlahovic TC; Coronado D; Chanda S; Merchant T; Zane LT
    J Drugs Dermatol; 2016 Jan; 15(1):89-94. PubMed ID: 26741386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective Survey of Treatment Outcomes of Efinaconazole 10% Solution and Luliconazole 5% Solution for Onychomycosis in Our Facility.
    Shimoyama H; Kuwano Y; Sei Y
    Med Mycol J; 2019; 60(4):95-100. PubMed ID: 31787733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efinaconazole (Jublia) for the treatment of onychomycosis.
    Gupta AK; Simpson FC
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):743-52. PubMed ID: 24850511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.